{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:22:33Z","timestamp":1789042953669,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T00:00:00Z","timestamp":1639872000000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The neutrophil-to-lymphocyte ratio (NLR) as an inflammatory marker may represent changes between inflammation and host immunity that affect the prognosis of peripheral T-cell lymphoma (PTCL). To comprehensively evaluate the NLR in PTCL, we performed a meta-analysis to investigate the relationship between the NLR and overall survival (OS) and progression-free survival (PFS). PubMed, Embase, Cochrane library, and China National Knowledge Infrastructure (CNKI) were searched for all relevant studies. Hazard ratios (HRs) and 95% confidence intervals (CIs) were obtained from each study. Heterogeneity among the included studies was checked to determine whether fixed or random effects model was used. In total, 8 studies with 921 patients were included for the meta-analysis. High NLR significantly correlated with worse OS (HR\u2009=\u20092.20, 95% CI 1.71\u20132.83, P\u2009&lt;\u20090.05) regardless of region (Asian or non-Asian), sample size (&lt;\u200960 or\u2009\u2265\u200960), median age (&lt;\u200960 or\u2009\u2265\u200960), disease type, or cut-off value (NLR\u2009&lt;\u20093.9 or NLR\u2009\u2265\u20093.9). In terms of PFS, the NLR had no prognostic impact for patients with PTCL (HR\u2009=\u20091.12, 95% CI 0.57\u20132.20, P\u2009=\u20090.742). Our findings suggest that PTCL patients with high NLR are more likely to have worse OS compared to those with low NLR. Therefore, the NLR can serve as a prognostic marker in PTCL.<\/jats:p>","DOI":"10.1186\/s12935-021-02391-z","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T07:02:23Z","timestamp":1639897343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prognostic significance of the neutrophil-to-lymphocyte ratio in peripheral T-cell lymphoma: a meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-5276","authenticated-orcid":false,"given":"Qingsong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,19]]},"reference":[{"issue":"Suppl 1","key":"2391_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/ijlh.12817","volume":"40","author":"E Matutes","year":"2018","unstructured":"Matutes E. The 2017 WHO update on mature T-and natural killer (NK) cell neoplasms. Int J Lab Hematol. 2018;40(Suppl 1):97\u2013103.","journal-title":"Int J Lab Hematol"},{"key":"2391_CR2","doi-asserted-by":"publisher","first-page":"623924","DOI":"10.5402\/2011\/623924","volume":"2011","author":"AN Abouyabis","year":"2011","unstructured":"Abouyabis AN, Shenoy PJ, Sinha R, et al. A systematic review and meta-analysis of front-line anthracycline-based chemotherapy regimens for peripheral T-cell lymphoma. ISRN Hematol. 2011;2011:623924.","journal-title":"ISRN Hematol"},{"issue":"25","key":"2391_CR3","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, et al. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124\u201330.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2391_CR4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.hoc.2019.04.002","volume":"33","author":"SY Ng","year":"2019","unstructured":"Ng SY, Jacobsen ED. Peripheral T-cell lymphoma: moving toward targeted therapies. Hematol Oncol Clin North Am. 2019;33(4):657\u201368.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"14","key":"2391_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329(14):987\u201394.","journal-title":"N Engl J Med"},{"key":"2391_CR6","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004;103:2474\u20139.","journal-title":"Blood"},{"issue":"3","key":"2391_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Yoon DH, Jaccard A, et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(3):389\u2013400.","journal-title":"Lancet Oncol"},{"key":"2391_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12935-019-0993-9","volume":"19","author":"S Zhang","year":"2019","unstructured":"Zhang S, Li M, Yuan F, et al. The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK\/T cell lymphoma [published correction appears in Cancer Cell Int. 2020 Jan 16; 20:21]. Cancer Cell Int. 2019;19:272.","journal-title":"Cancer Cell Int"},{"issue":"06","key":"2391_CR9","first-page":"536","volume":"11","author":"H Xin","year":"2019","unstructured":"Xin H, Hong C. Research progress on the relationship between peripheral blood inflammatory markers and prognosis of diffuse large B-cell lymphoma. Chin J Cancer Prev. 2019;11(06):536\u201340.","journal-title":"Chin J Cancer Prev"},{"issue":"1","key":"2391_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13058-016-0794-1","volume":"19","author":"JL Ethier","year":"2017","unstructured":"Ethier JL, Desautels D, Templeton A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19(1):2.","journal-title":"Breast Cancer Res"},{"issue":"4","key":"2391_CR11","first-page":"587","volume":"8","author":"H Murata","year":"2018","unstructured":"Murata H, Koyama K, Takezawa Y, et al. Baseline neutrophil-to-lymphocyte ratio predicts the prognosis of castration-resistant prostate cancer treated with abiraterone acetate. Mol Clin Oncol. 2018;8(4):587\u201391.","journal-title":"Mol Clin Oncol"},{"key":"2391_CR12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","volume":"111","author":"S Diem","year":"2017","unstructured":"Diem S, Schmid S, Krapf M, et al. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer. 2017;111:176\u201381.","journal-title":"Lung Cancer"},{"issue":"4","key":"2391_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/bjh.15054","volume":"180","author":"JP Reddy","year":"2018","unstructured":"Reddy JP, Hernandez M, Gunther JR, et al. Pre-treatment neutrophil\/lymphocyte ratio and platelet\/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma. Br J Haematol. 2018;180(4):545\u20139.","journal-title":"Br J Haematol"},{"issue":"2","key":"2391_CR14","first-page":"489","volume":"27","author":"YQ Sun","year":"2019","unstructured":"Sun YQ, Li QF, Zhang QK, et al. Significance of neutrophil\/lymphocyte ratio in prognosis of patients with multiple myeloma. Chin J Exp Hematol. 2019;27(2):489\u201393.","journal-title":"Chin J Exp Hematol"},{"key":"2391_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12935-018-0609-9","volume":"18","author":"S Mu","year":"2018","unstructured":"Mu S, Ai L, Fan F, et al. Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis. Cancer Cell Int. 2018;18:119.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"2391_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"2391_CR17","first-page":"866","volume":"28","author":"YQ Yang","year":"2020","unstructured":"Yang YQ, He HS, Dai Y, et al. Neutrophil-lymphocyte ratio as a prognostic predictor in patients with newly diagnosed angioimmunoblastic T cell lymphoma. J Exp Hematol. 2020;28(3):866\u201371.","journal-title":"J Exp Hematol"},{"key":"2391_CR18","doi-asserted-by":"publisher","first-page":"593392","DOI":"10.3389\/fphar.2020.593392","volume":"11","author":"H Huang","year":"2020","unstructured":"Huang H, Chen LM, Fang XJ, et al. Prognostic value of the modified systemic inflammation score in patients with extranodal natural killer\/T-cell lymphoma. Front Pharmacol. 2020;11:593392.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2391_CR19","first-page":"241","volume":"43","author":"WZ Feng","year":"2020","unstructured":"Feng WZ, Ouyang CT, Yu SS, et al. Prognostic analysis of neutrophil\/lymphocyte ratio and lymphocyte\/monocyte ratio in patients with peripheral, T-cell lymphoma. Int J Blood Transfus Hematol. 2020;43(3):241\u201350.","journal-title":"Int J Blood Transfus Hematol"},{"issue":"05","key":"2391_CR20","first-page":"15","volume":"16","author":"L Zhang","year":"2019","unstructured":"Zhang L, Song XY, Yu SS, et al. The relationship between pretreatment neutrophil to lymphocyte ratio and prognosis in patients with nasal-type extranodal NK\/T-cell lymphoma. Pract J Clin Med. 2019;16(05):15\u20139.","journal-title":"Pract J Clin Med"},{"issue":"1","key":"2391_CR21","doi-asserted-by":"publisher","first-page":"14961","DOI":"10.1038\/s41598-019-51522-0","volume":"9","author":"KM Tan","year":"2019","unstructured":"Tan KM, Chia B, Lim JQ, et al. A clinicohaematological prognostic model for nasal-type natural killer\/T-cell lymphoma: a multicenter study. Sci Rep. 2019;9(1):14961.","journal-title":"Sci Rep"},{"issue":"3","key":"2391_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000495337","volume":"141","author":"M Choi","year":"2019","unstructured":"Choi M, Lee JO, Jung J, et al. Prognostic value of platelet count in patients with peripheral T cell lymphoma. Acta Haematol. 2019;141(3):176\u201386.","journal-title":"Acta Haematol"},{"issue":"4","key":"2391_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjh.15141","volume":"184","author":"BE Beltran","year":"2019","unstructured":"Beltran BE, Castro D, De La Cruz-Vargas JA, et al. The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma. Br J Haematol. 2019;184(4):650\u20133.","journal-title":"Br J Haematol"},{"issue":"1","key":"2391_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3109\/10428194.2015.1045897","volume":"57","author":"BE Beltran","year":"2016","unstructured":"Beltran BE, Aguilar C, Qui\u00f1ones P, et al. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2016;57(1):58\u201362.","journal-title":"Leuk Lymphoma"},{"issue":"6917","key":"2391_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature"},{"issue":"3","key":"2391_CR26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s13277-014-2776-1","volume":"36","author":"L Wang","year":"2015","unstructured":"Wang L, Wang JH, Wu-Xiao ZJ, et al. Lymphopenia during routine follow-up may predict relapse in patients with extranodal NK\/T cell lymphoma. Tumour Biol. 2015;36(3):1747\u201353.","journal-title":"Tumour Biol"},{"issue":"4","key":"2391_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1023\/B:AGEN.0000029415.62384.ba","volume":"6","author":"YH Kusumanto","year":"2003","unstructured":"Kusumanto YH, Dam WA, Hospers GA, et al. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6(4):283\u20137.","journal-title":"Angiogenesis"},{"issue":"4","key":"2391_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12185-017-2362-6","volume":"107","author":"S Kaito","year":"2018","unstructured":"Kaito S, Kanemasa Y, Sasaki Y, et al. A new prognostic score comprising lactate dehydrogenase, albumin and neutrophil to lymphocyte ratio to predict sensitivity to first-line chemotherapy in patients with peripheral T-cell lymphomas. Int J Hematol. 2018;107(4):451\u20139.","journal-title":"Int J Hematol"},{"issue":"3","key":"2391_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/10428194.2019.1700244","volume":"61","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H, et al. The prognostic value of platelet-lymphocyte ratio and neutrophil-lymphocyte ratio in the treatment response and survival of patients with peripheral T-cell lymphoma. Leuk Lymphoma. 2020;61(3):623\u201330.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2391_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11899-010-0062-x","volume":"5","author":"PP Piccaluga","year":"2010","unstructured":"Piccaluga PP, Agostinelli C, Gazzola A, et al. Prognostic markers in peripheral T-cell lymphoma [published correction appears in Curr Hematol Malig Rep. 2010 Oct;5(4):239]. Curr Hematol Malig Rep. 2010;5(4):222\u20138.","journal-title":"Curr Hematol Malig Rep"},{"issue":"4","key":"2391_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/MOH.0000000000000355","volume":"24","author":"W Ren","year":"2017","unstructured":"Ren W, Li W, Ye X, et al. Distinct subtype distribution and somatic mutation spectrum of lymphomas in East Asia. Curr Opin Hematol. 2017;24(4):367\u201376.","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"2391_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1346-8138.12299","volume":"41","author":"T Hamada","year":"2014","unstructured":"Hamada T, Iwatsuki K. Cutaneous lymphoma in Japan: a nationwide study of 1733 patients. J Dermatol. 2014;41(1):3\u201310.","journal-title":"J Dermatol"},{"issue":"5","key":"2391_CR33","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/cas.14869","volume":"112","author":"K Nosaka","year":"2021","unstructured":"Nosaka K, Matsuoka M. Adult T-cell leukemia-lymphoma as a viral disease: subtypes based on viral aspects. Cancer Sci. 2021;112(5):1688\u201394.","journal-title":"Cancer Sci"},{"issue":"11","key":"2391_CR34","first-page":"641","volume":"23","author":"J Ma","year":"2014","unstructured":"Ma J, Zhu J, Shi Y-K, et al. T cell lymphoma: a review of the 2014 international conference on clinical treatment of T cell lymphoma. Leuk Lymphoma. 2014;23(11):641-645+653.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"2391_CR35","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","volume":"101","author":"AM Perry","year":"2016","unstructured":"Perry AM, Diebold J, Nathwani BN, et al. Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project. Haematologica. 2016;101(10):1244\u201350.","journal-title":"Haematologica"},{"issue":"8","key":"2391_CR36","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","volume":"112","author":"YX Li","year":"2008","unstructured":"Li YX, Fang H, Liu QF, et al. Clinical features and treatment outcome of nasal-type NK\/T-cell lymphoma of Waldeyer ring. Blood. 2008;112(8):3057\u201364.","journal-title":"Blood"},{"issue":"12","key":"2391_CR37","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1182\/blood-2015-04-639336","volume":"126","author":"Y Yang","year":"2015","unstructured":"Yang Y, Zhu Y, Cao JZ, et al. Risk-adapted therapy for early-stage extranodal nasal-type NK\/T-cell lymphoma: analysis from a multicenter study. Blood. 2015;126(12):1424\u201332.","journal-title":"Blood"},{"issue":"2","key":"2391_CR38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/cncr.27752","volume":"119","author":"L Wang","year":"2013","unstructured":"Wang L, Wang ZH, Chen XQ, et al. First-line combination of gemcitabine, oxaliplatin, and l-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE\/IIE extranodal natural killer\/T-cell lymphoma. Cancer. 2013;119(2):348\u201355.","journal-title":"Cancer"},{"issue":"7","key":"2391_CR39","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3109\/10428194.2015.1108415","volume":"57","author":"LH Dong","year":"2016","unstructured":"Dong LH, Zhang LJ, Wang WJ, et al. Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK\/T-cell lymphoma. Leuk Lymphoma. 2016;57(7):1600\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2391_CR40","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","volume":"34","author":"SV Adams","year":"2016","unstructured":"Adams SV, et al. Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States. J Clin Oncol. 2016;34(9):963\u201371.","journal-title":"J Clin Oncol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-021-02391-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-021-02391-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-021-02391-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T19:05:48Z","timestamp":1639940748000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-021-02391-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1186\/s12935-021-02391-z","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"24 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"688"}}